Peter Wipf
Vieraileva tutkija
Farmasian laitos, Terveystieteiden tiedekunta
peter.wipf@uef.fi
Julkaisut
5/5 kappaletta-
Hydroxamic Acids as PARP-1 Inhibitors: Molecular Design and Anticancer Activity of Novel Phenanthridinones
Bondar, Denys; Bragina, Olga; Lee, Ji Young; Semenyuta, Ivan; Järving, Ivar; Brovarets, Volodymyr; Wipf, Peter; Bahar, Ivet; Karpichev, Yevgen. 2023. Helvetica chimica acta. 106: . e202300133 -
Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype
Hernandez, Ciria C.; Tarfa, Rahilla A.; Miguel I. Limcaoco, Jose; Liu, Ruiting; Mondal, Pravat; Hill, Clare; Keith Duncan, R.; Tzounopoulos, Thanos; Stephenson, Corey R.J.; O'Meara, Matthew J.; Wipf, Peter. 2022. Bioorganic and medicinal chemistry letters. 71: -
Recent syntheses and biological profiling of quassinoids
Pazur, Ethan J; Wipf, Peter. 2022. Organic and biomolecular chemistry. 20: 3870-3889 -
Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions
Wang, Qiming Jane; Wipf, Peter. 2022. Journal of medicinal chemistry. 2023; 66: 122-139 -
Stereoselective synthesis of δ-fluorinated isoleucines exploiting consecutive C(sp3)-H bond activations
Borgini, Matteo; Wipf, Peter. 2022. Tetrahedron. 120: . 132876